Anything Technologies Media acquires Frontier Indoor Backyard Solutions Anything Technologies Media.
Related StoriesResearch: Heavy drinkers, illegal drug users downplay their intake levels in comparison to othersEndocannabinoids can affect development of baby's pancreasDigiPath Labs, Romer Labs to validate kit-based assays for food-borne pathogen, mycotoxin assessment for cannabis’I am extremely excited to not only join forces with ATM's resources and contacts in the medical cannabis industry, but to likewise have their confidence in allowing Frontier's vision to anchor the future of the company.’ stated Frontier President Jim Filkins.It might trigger a second effect not seen in vitro or in mice. So sometimes that could be a fever or headaches or something like that. At the biological level there are variations between a mouse model and human, so I think this is quite a fascinating project. However in clinical advancement you hardly ever know if it’s going to reach a successful end, Lafaye tells youis.com. Lafaye says that monoclonal antibodies experienced a major impact in the field of cancer therapy. However, not so much in autoimmune diseases. Asked about alternative strategies for organ transplants, he says: A small chemical compound that is able to interact with TLR-2 can work, but these little compounds usually have a short half-life [which implies that they don’t necessarily stay long plenty of in your body to end up being effective].